BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33837479)

  • 1. A case of a rosette-forming glioneuronal tumor with clinicopathological features of a dysembryoplastic neuroepithelial tumor and fibroblast growth factor receptor 1 internal tandem duplication.
    Uchiyama T; Gomi A; Nobusawa S; Fukushima N; Matsubara D; Kawai K
    Brain Tumor Pathol; 2021 Jul; 38(3):250-256. PubMed ID: 33837479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant transformation of a dysembryoplastic neuroepithelial tumor verified by a shared copy number gain of the tyrosine kinase domain of FGFR1.
    Matsumura N; Natsume A; Maeda S; Aoki K; Yamazaki T; Nobusawa S; Yokoo H
    Brain Tumor Pathol; 2020 Apr; 37(2):69-75. PubMed ID: 32297014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumor.
    Lucas CG; Gupta R; Doo P; Lee JC; Cadwell CR; Ramani B; Hofmann JW; Sloan EA; Kleinschmidt-DeMasters BK; Lee HS; Wood MD; Grafe M; Born D; Vogel H; Salamat S; Puccetti D; Scharnhorst D; Samuel D; Cooney T; Cham E; Jin LW; Khatib Z; Maher O; Chamyan G; Brathwaite C; Bannykh S; Mueller S; Kline CN; Banerjee A; Reddy A; Taylor JW; Clarke JL; Oberheim Bush NA; Butowski N; Gupta N; Auguste KI; Sun PP; Roland JL; Raffel C; Aghi MK; Theodosopoulos P; Chang E; Hervey-Jumper S; Phillips JJ; Pekmezci M; Bollen AW; Tihan T; Chang S; Berger MS; Perry A; Solomon DA
    Acta Neuropathol Commun; 2020 Aug; 8(1):151. PubMed ID: 32859279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A peculiar histopathological form of dysembryoplastic neuroepithelial tumor with separated pilocytic astrocytoma and rosette-forming glioneuronal tumor components.
    Matyja E; Grajkowska W; Kunert P; Marchel A
    Neuropathology; 2014 Oct; 34(5):491-8. PubMed ID: 24735014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of recurrent epilepsy-associated rosette-forming glioneuronal tumor with anaplastic transformation in the absence of therapy.
    Halfpenny A; Ferris SP; Grafe M; Woltjer R; Selden N; Nazemi K; Perry A; Solomon DA; Gultekin SH; Moore S; Olson S; Lawce H; Lucas L; Corless CL; Wood MD
    Neuropathology; 2019 Oct; 39(5):389-393. PubMed ID: 31435988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Droplet digital PCR is a powerful technique to demonstrate frequent FGFR1 duplication in dysembryoplastic neuroepithelial tumors.
    Fina F; Barets D; Colin C; Bouvier C; Padovani L; Nanni-Metellus I; Ouafik L; Scavarda D; Korshunov A; Jones DT; Figarella-Branger D
    Oncotarget; 2017 Jan; 8(2):2104-2113. PubMed ID: 27791984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intractable epilepsy due to a rosette-forming glioneuronal tumor with a dysembryoplastic neuroepithelial background.
    Sumitomo N; Ishiyama A; Shibuya M; Nakagawa E; Kaneko Y; Takahashi A; Otsuki T; Kakita A; Saito Y; Sato N; Sugai K; Sasaki M
    Neuropathology; 2018 Jun; 38(3):300-304. PubMed ID: 29250844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplex ligation-dependent probe amplification analysis is useful for detecting a copy number gain of the FGFR1 tyrosine kinase domain in dysembryoplastic neuroepithelial tumors.
    Matsumura N; Nobusawa S; Ito J; Kakita A; Suzuki H; Fujii Y; Fukuda M; Iwasaki M; Nakasato N; Tominaga T; Natsume A; Mikami Y; Shinojima N; Yamazaki T; Nakazato Y; Hirato J; Yokoo H
    J Neurooncol; 2019 May; 143(1):27-33. PubMed ID: 30825062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed glioneuronal tumor: a dysembryoplastic neuroepithelial tumor with rosette-forming glioneuronal tumor component.
    Xiong J; Ding L; Chen H; Chen H; Wang Y
    Neuropathology; 2013 Aug; 33(4):431-5. PubMed ID: 23163721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIK3CA mutation in a mixed dysembryoplastic neuroepithelial tumor and rosette forming glioneuronal tumor, a case report and literature review.
    Eye PG; Davidson L; Malafronte PJ; Cantrell S; Theeler BJ
    J Neurol Sci; 2017 Feb; 373():280-284. PubMed ID: 28131206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glioneuronal tumours with features of rosette-forming glioneuronal tumours of the fourth ventricle and dysembryoplastic neuroepithelial tumours: a report of three cases.
    Chen SY; Wang W; Wang LM; Lin QT; Zhao GG; Xu G; Lu DH; Piao YS
    Histopathology; 2016 Feb; 68(3):378-87. PubMed ID: 26040650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive genetic characterization of rosette-forming glioneuronal tumors: independent component analysis by tissue microdissection.
    Kitamura Y; Komori T; Shibuya M; Ohara K; Saito Y; Hayashi S; Sasaki A; Nakagawa E; Tomio R; Kakita A; Nakatsukasa M; Yoshida K; Sasaki H
    Brain Pathol; 2018 Jan; 28(1):87-93. PubMed ID: 27893178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Multifocal Glioneuronal Tumor with RGNT-Like Morphology Occupying the Supratentorial Ventricular System and Infiltrating the Brain Parenchyma.
    Morassi M; Vivaldi O; Cobelli M; Liserre B; Zorzi F; Bnà C
    World Neurosurg; 2020 Jan; 133():196-200. PubMed ID: 31606508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An epilepsy-associated glioneuronal tumor with mixed morphology harboring FGFR1 mutation.
    Yamada S; Nobusawa S; Yamazaki T; Teranishi T; Watanabe S; Murayama K; Ohba S; Okabe A; Sakurai K; Urano M; Tsukamoto T; Yokoo H; Hirose Y; Abe M
    Pathol Int; 2019 Jun; 69(6):372-377. PubMed ID: 31218776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosette-forming glioneuronal tumours are midline, FGFR1-mutated tumours.
    Appay R; Bielle F; Sievers P; Barets D; Fina F; Boutonnat J; Adam C; Gauchotte G; Godfraind C; Lhermitte B; Maurage CA; Meyronet D; Mokhtari K; Rousseau A; Tauziède-Espariat A; Tortel MC; Uro-Coste E; Burel-Vandenbos F; Chotard G; Pesce F; Varlet P; Colin C; Figarella-Branger D
    Neuropathol Appl Neurobiol; 2022 Aug; 48(5):e12813. PubMed ID: 35293634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological analysis of rosette-forming glioneuronal tumors.
    Liu J; Lin F; Sun Y; Liu X
    Diagn Pathol; 2024 Feb; 19(1):39. PubMed ID: 38388383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enrichment of oligodendrocyte precursor phenotypes in subsets of low-grade glioneuronal tumours.
    Duan Z; Feng J; Guan Y; Li S; Wu B; Shao Y; Ma Z; Hu Z; Xiang L; Zhu M; Fan X; Qi X
    Brain Commun; 2024; 6(3):fcae156. PubMed ID: 38764775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncommon Glioneuronal Tumors: A Radiologic and Pathologic Synopsis.
    Vaz A; Cavalcanti MS; da Silva Junior EB; Ramina R; de Almeida Teixeira BC
    AJNR Am J Neuroradiol; 2022 Aug; 43(8):1080-1089. PubMed ID: 35512827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noonan syndrome, PTPN11 mutations, and brain tumors. A clinical report and review of the literature.
    Siegfried A; Cances C; Denuelle M; Loukh N; Tauber M; Cavé H; Delisle MB
    Am J Med Genet A; 2017 Apr; 173(4):1061-1065. PubMed ID: 28328117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olig2-positive cells in glioneuronal tumors show both glial and neuronal characters: the implication of a common progenitor cell?
    Matsumura N; Yokoo H; Mao Y; Yin W; Nakazato Y
    Neuropathology; 2013 Jun; 33(3):246-55. PubMed ID: 23025580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.